BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 26364276)

  • 1. S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
    Ambrée O; Bergink V; Grosse L; Alferink J; Drexhage HA; Rothermundt M; Arolt V; Birkenhäger TK
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv103. PubMed ID: 26364276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
    Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
    Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E; Feighner J; Mandos LA; Rickels K
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers.
    Navinés R; Oriolo G; Horrillo I; Cavero M; Aouizerate B; Schaefer M; Capuron L; Meana JJ; Martin-Santos R
    Int J Neuropsychopharmacol; 2022 Jun; 25(6):468-478. PubMed ID: 35176771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy.
    Carlier A; Boers K; Veerhuis R; Bouckaert F; Sienaert P; Eikelenboom P; Vandenbulcke M; Stek ML; van Exel E; Dols A; Rhebergen D
    Psychoneuroendocrinology; 2019 Dec; 110():104414. PubMed ID: 31493698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients.
    Vermeiden M; Kamperman AM; Vulink ME; van den Broek WW; Birkenhäger TK
    Psychopharmacology (Berl); 2015 Apr; 232(8):1347-56. PubMed ID: 25338776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.
    Heijnen WT; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):559-63. PubMed ID: 19028834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.
    Vermeiden M; Mulder PG; van den Broek WW; Bruijn JA; Birkenhäger TK
    J Psychiatr Res; 2013 Oct; 47(10):1337-42. PubMed ID: 23800419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine.
    Simon GE; Heiligenstein JH; Grothaus L; Katon W; Revicki D
    J Clin Psychiatry; 1998 Feb; 59(2):49-55. PubMed ID: 9501885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of BDNF, S100B, and oxidative stress in interferon-induced depression and the effect of antidepressant treatment in patients with chronic viral hepatitis: a prospective study.
    Cicek IE; Cicek E; Kayhan F; Uguz F; Erayman I; Kurban S; Yerlikaya FH; Kaya N
    J Psychosom Res; 2014 Mar; 76(3):227-32. PubMed ID: 24529042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
    Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF).
    Deuschle M; Gilles M; Scharnholz B; Kahl KG
    Pharmacopsychiatry; 2015 Nov; 48(7):292-3. PubMed ID: 26190286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
    Smagula SF; Butters MA; Anderson SJ; Lenze EJ; Dew MA; Mulsant BH; Lotrich FE; Aizenstein H; Reynolds CF
    JAMA Psychiatry; 2015 Oct; 72(10):1021-8. PubMed ID: 26288246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to Imipramine Versus Add-on Mirtazapine in Venlafaxine-Resistant Major Depression: A 10-Week Randomized Open Study.
    Navarro V; Boulahfa I; Obach A; Jerez D; Diaz-Ricart M; Gastó C; Guarch J
    J Clin Psychopharmacol; 2019; 39(1):63-66. PubMed ID: 30516574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.
    Wang CH; Gu JY; Zhang XL; Dong J; Yang J; Zhang YL; Ning QF; Shan XW; Li Y
    Behav Brain Funct; 2016 Dec; 12(1):34. PubMed ID: 27931233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100B and response to treatment in major depression: a pilot study.
    Arolt V; Peters M; Erfurth A; Wiesmann M; Missler U; Rudolf S; Kirchner H; Rothermundt M
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):235-9. PubMed ID: 12888182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.